Mammography screening recommendation pushed back to age 40, and pancreatic cancer vaccine shows promising immune response.

by Marci A. Landsmann

Researchers discover a new way breast density can impact cancer risk, and CAR T-cell therapy remains out of reach for patients with HIV.

by Thomas Celona

More programs address sexual health in cancer survivors, and survey suggests health insurance often doesn’t cover genetic tumor testing.

by Marci A. Landsmann

Awareness of HPV link to cancer has declined, and more frequent COVID-19 boosters authorized for people who are immunocompromised.

by Eric Fitzsimmons

Treatment vaccines are on the horizon, and immunotherapy drugs are effective in treating multiple myeloma.

by Kevin McLaughlin

New therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.

by Thomas Celona

Immunotherapies poised to change care in advanced endometrial cancer, and the end of pandemic protection expected to result in loss of health coverage for 15 million people.

by Eric Fitzsimmons

Drug shortage affects patients with advanced prostate cancer, and military pilots and ground crews have increased cancer rates.

by Marci A. Landsmann

Active monitoring a viable choice for some with prostate cancer, and cancer’s effects on women’s sexual activity not addressed by providers.

by Kevin McLaughlin

The FDA sets rule that requires mammography providers to notify women who have dense breasts, and the ‘Jimmy Carter effect’ on immunotherapy treatment.

by Eric Fitzsimmons